SCHEMBL7182976

SCHEMBL7182976

Cc1cccc2n[c]oc(=O)c12

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ELANE P08246 19/20 0.53
CTRB1 P17538 1/20 0.44
C1R P00736 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180694 0.79 C1R (0.36) ELANEC1R
SCHEMBL940408 0.73 ELANE (0.34) ELANE
SCHEMBL2515687 0.71 ELANE (0.46) ELANE
SCHEMBL282843 0.69 ELANE (1.00) ELANECTRB1C1R
SCHEMBL6537314 0.69 ELANE (1.00) ELANECTRB1
SCHEMBL23295733 0.67 ELANE (0.39) ELANECTRB1
SCHEMBL8543622 0.67 ELANE (0.70) ELANECTRB1C1R
SCHEMBL8016730 0.66 ELANE (0.76) ELANECTRB1C1R
SCHEMBL8006834 0.65 C1R (0.81) ELANEC1R
SCHEMBL10657051 0.65 ELANE (1.00) ELANECTRB1C1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003007955-A2 BIPHENYL APURINIC/APYRIMIDINIC SITE ENDONUCLEASE INHIBITORS TO TREAT CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2003-01-30 WO disclosed